Myelofibrosis
Showing 1 - 25 of 577
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,
Recruiting
- Primary Myelofibrosis
- +2 more
- NS-018
- Best Available Therapy
-
Ipoh, Perak, MalaysiaHospital Raja Permaisuri Bainun
Jul 18, 2022
Assess Real-World Patient-Reported Outcomes With Fedratinib for
Recruiting
- Myelofibrosis
-
City, State, AustriaLocal Institution
Dec 16, 2022
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)
Recruiting
- Primary Myelofibrosis
- +4 more
-
New York, New YorkRuttenberg Treatment Center
Jul 18, 2022
Myelofibrosis Trial in France (Clonal architecture determination)
Not yet recruiting
- Myelofibrosis
- Clonal architecture determination
-
Angers, France
- +6 more
Jan 24, 2023
Myelofibrosis Trial in Jinan (Ruxolitinib)
Recruiting
- Myelofibrosis
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jul 3, 2022
Myelofibrosis Trial in Hong Kong (Bomedemstat)
Recruiting
- Myelofibrosis
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Oct 3, 2022
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
-
Saint Louis, MissouriWashington University School of Medicine
May 6, 2022
Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Long-term Follow-up
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Fedratinib Oral Capsule [Inrebic]
- Nivolumab
-
Greifswald, Germany
- +1 more
Jun 15, 2022
Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablet
- (no location specified)
Mar 3, 2022
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 7, 2022
A Prospective, Two-arm, Non-interventional Study of JAKAVI® in
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Jakavi
-
Aachen, GermanyNovartis Investigative Site
Sep 6, 2021
Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
-
Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
Mar 17, 2022
Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)
Recruiting
- Primary Myelofibrosis, Prefibrotic Stage
- Myelofibrosis
- Ropeginterferon alfa-2b
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021